| 臺大學術典藏 |
2021-05-31T02:56:57Z |
Tocotrienols for bone health: a translational approach
|
Shen C.-L.; Klein A.; Chin K.-Y.; Mo H.; Tsai P.; RONG-SEN YANG; Chyu M.-C.; Ima-Nirwana S. |
| 嘉南藥理大學 |
2010-02 |
Tocotrienols Inhibited Growth and Induced Apoptosis in Human HeLa Cells Through the Cell Cycle Signaling Pathway
|
Shu-Jing Wu; Lean-Teik Ng |
| 臺大學術典藏 |
2018-09-10T08:11:01Z |
Tocotrienols inhibited growth and induced apoptosis in human HeLa cells through the cell cycle signaling pathway
|
Wu, S.-J.; Ng, L.-T.; LEAN-TEIK HUANG |
| 國立交通大學 |
2014-12-12T01:53:19Z |
TOC之S-DBR應用於太陽能電池生產管控之實踐: 以E公司為例
|
王進財; 李榮貴 |
| 國立交通大學 |
2014-12-13T10:34:48Z |
TOC供應鏈應用Solution強化研究(I)
|
李榮貴; LI RONG-KWEI |
| 國立成功大學 |
2004-06-23 |
TOC式扣件生產系統之模擬實例研究
|
張喬齡; Chang, Chiao-Ling |
| 國立成功大學 |
2009-07-09 |
TOC式煉鋼生產系統模擬實例研究
|
陳嶽漢; Chen, Yueh-Han |
| 國立交通大學 |
2015-11-26T01:07:35Z |
TOC拉式補貨模式適用環境之研究
|
賴詩婷; Lai, Shih-Ting; 洪瑞雲; Horng, Ruey-Yun |
| 國立成功大學 |
2011-07-11 |
TOC模式應用在彩色濾光片生產排程
|
林博仁; Lin, Po-Jen |
| 國立交通大學 |
2014-12-12T02:49:43Z |
TOC運用於熱導管生產管理之研究
|
廖敏雄; 李榮貴 |
| 國立交通大學 |
2014-12-12T01:17:51Z |
TOC配銷管理模擬器之開發
|
蔡佳玲; Chia-Ling Tsai; 李榮貴; Rong-Kwei Li |
| 中國文化大學 |
2016 |
TOD District planning based on resident's perspectives
|
李家儂等撰 |
| 中國文化大學 |
2016-04 |
TOD District Planning Based on Residents' Perspectives
|
Li, CN (Li, Chia-Nung); Lin, C (Lin, Chiang); Hsieh, TK (Hsieh, Tsu-Kuang) |
| 南台科技大學 |
2001-12 |
Today's E-commerce of Hospitality Industry in Taiwan
|
萬金生; 楊景雍 |
| 國立臺灣科技大學 |
2015-07-18 |
Today’s Special手作食刻
|
林雨蓉, 曹雅筑 |
| 國立臺灣大學 |
2012 |
Toddler autism screening questionnaire: Development and potential clinical validity
|
Tsai, Wen-Che; Soong, Wei-Tsuen; Shyu, Yea-Ing Lotus; 蔡文哲 |
| 東海大學 |
2009 |
Todo en chino sobre España y lo español en la Red
|
Rubio Lastra, M.; 路昇融 |
| 實踐大學 |
2013 |
TOD及小區規劃單元觀念之操作—以汐止城中區為例
|
沈耕平; Shen, Ken Ping |
| 中國醫藥大學 |
2010-07 |
Toe-out Landing Position Increases Medial Ground Reaction Force during Walking in Young Individuals
|
鐘進燈(Chung CT); 楊鎮嘉(Yang CC); 邱靖華(Chiu CH); 林家弘(Lin CH); 謝悅齡(Yueh-Ling Hsieh)* |
| 中國醫藥大學 |
2010-07 |
Toe-out Landing Position Increases Medial Ground Reaction Force during Walking in Young Individuals
|
鐘進燈(Chung CT); 楊鎮嘉(Yang CC); 邱靖華(Chiu CH); 林家弘(Lin CH); 謝悅齡(Yueh-Ling Hsieh)* |
| 淡江大學 |
1990 |
TOEFL CAI
|
陳惠美 |
| 中國文化大學 |
2005-07-01 |
TOEFL Listening Comprehension Test-Statistical Evaluation of a Practice Examination on Two Language Classes
|
莫考利; 邱美清 |
| 國立政治大學 |
2010 |
Toeic 900. I
|
陳超明 |
| 國立政治大學 |
2010 |
Toeic 900. II
|
陳超明 |
| 輔英科技大學 |
2009-11-06 |
TOEIC-related Texts in Translation Class: a language learning course as cultural discourse
|
Kao, Chia-Hsuan |
| 國立政治大學 |
2011 |
TOEIC900一生必學的英文聽力 = Test of English for international communication
|
陳超明 |
| 輔英科技大學 |
2003-11-01 |
TOEIC多益聽力寶典
|
楊玉琦 |
| 輔英科技大學 |
2003-06-01 |
TOEIC常考字彙片語
|
楊玉琦 |
| 致理技術學院 |
2017-07 |
TOEIC挑戰王
|
劉泰宏; 江泰鋒; 洪丞毅; 陳思婷; 侯欣言; 謝孟軒 |
| 正修科技大學 |
2009 |
TOEIC教學研討會-『職場英語』教學法師資培訓
|
莊媖纓 |
| 中山醫學大學 |
2013-04-15 |
TOEIC校園考--考取965分的訣竅
|
李宗翰, 醫學一 |
| 國立臺灣大學 |
2009 |
ToeOFF®踝足矯具在改善腦中風病患歩態上之果效
|
吳佩育; Wu, Pei-Yu |
| 中原大學 |
2000-12 |
Toeplitz Matrix for Non-Coherent and Coherent Signals in MUSIC Algorithm
|
Chang, Yuh-Huu;Liu, Chi-Kang |
| 中原大學 |
2000 |
Toeplitz Matrix在陣列天線中方向估測的應用
|
劉志剛; Chi Kang Liu |
| 國立高雄師範大學 |
2001-07-24 |
TOF resolution and calibration at SPring-8/LEPS
|
蔡俊明 |
| 國立臺灣大學 |
2011 |
ToF-SIMS imaging of the nanoscale phase separation in polymeric light emitting diodes: Effect of nanostructure on device efficiency
|
Yu, Bang-Ying; Kuo, Che-Hung; Wang, Wei-Ben; Yen, Guo-Ji; Iida, Shin-ichi; Chen, Sun-Zen; Lin, Wei-Chun; Lee, Szu-Hsian; Kao, Wei-Lun; Liu, Chia-Yi; Chang, Hsun-Yun; You, Yun-Wen; Chang, Chi-Jen; Liu, Chi-Ping; Jou, Jwo-Huei; Shyue, Jing-Jong |
| 臺大學術典藏 |
2020-09-02T09:05:48Z |
TOF-SIMS investigation of degradation pathways occurring in a variety of organic photovoltaic devices - The ISOS-3 inter-laboratory collaboration
|
YULIA GALAGAN; Norrman K.; Krebs F.C.; Bundgaard E.; Madsen M.V.; Jorgensen M.; Gevorgyan S.A.; Germack D.S.; Hösel M.; Dam H.F.; Uzunoglu G.Y.; Rivaton A.; Lira-Cantu M.; Teran-Escobar G.; Hoppe H.; Rösch R.; Zimmernann B.; Kudret S.; Maes W.; Lutsen L.; Vanderzande D.; Würfel U.; Andriessen R.; Galagan Y.; Lloyd M.T.; Andreasen B.; Tanenbaum D.M.; Hermenau M.; Voroshazi E. |
| 臺北醫學大學 |
2004 |
TOF-SIMS study of pyridine intercalated nanorods of bismuth molybdate
|
麥富德; Anil Vithal Ghul; Chin-Yuen Chen; Fu-Der Mai; Yong-Chien Ling; ; |
| 國立成功大學 |
2024-05-25 |
Tofacitinib ameliorates skin inflammation in a patient with severe autosomal recessive congenital ichthyosis
|
Lin;Yu-Chen;Hong;Yi-Kai;Jr, Aala;Wilson, F.;Hitomi;Kiyotaka;Akiyama;Masashi;Mcgrath;John, A.;Hsu;Chao-Kai |
| 國立成功大學 |
2024-01 |
Tofacitinib and pirfenidone as rescue therapies for severe COVID-19 in a patient with previously stable interstitial lung disease associated with Sjogren syndrome
|
Tsao;Yu-Chuan;Chuang;Shih-Han;Tseng;Chih-Wei |
| 中山醫學大學 |
2021 |
Tofacitinib as monotherapy following methotrexate withdrawal in patients with psoriatic arthritis previously treated with open-label tofacitinib plus methotrexate: a randomised, placebo-controlled substudy of OPAL Balance
|
Nash, P; Mease, PJ; Fleishaker, D; Wu, J; Coates, LC; Behrens, F; Gladman, DD; Kivitz, AJ; Wei, JC; Shirinsky, I; Menon, S; Romero, AB; Fallon, L; Hsu, MA; Wang, CS; Kanik, KS |
| 中山醫學大學 |
2020 |
TOFACITINIB AS MONOTHERAPY FOLLOWING METHOTREXATE WITHDRAWAL IN PATIENTS WITH PSORIATIC ARTHRITIS PREVIOUSLY TREATED WITH OPEN-LABEL TOFACITINIB plus METHOTREXATE: A RANDOMISED, PLACEBO-CONTROLLED SUBSTUDY OF OPAL BALANCE
|
Nash, P; Coates, LC; Mease, PJ; Kivitz, A; Gladman, DD; Behrens, F; Wei, JCC; Fleishaker, D; Wu, J; Wang, C; Romero, AB; Fallon, L; Hsu, MA; Kanik, K |
| 臺大學術典藏 |
2021-02-02T02:47:53Z |
Tofacitinib in Combination With Methotrexate in Patients With Rheumatoid Arthritis: Clinical Efficacy, Radiographic, and Safety Outcomes From a Twenty-Four–Month, Phase III Study
|
van der Heijde D.; Strand V.; Tanaka Y.; Keystone E.; Kremer J.; Zerbini C.A.F.; Cardiel M.H.; Cohen S.; Nash P.; Song Y.-W.; Tegzová D.; Gruben D.; Wallenstein G.; Connell C.A.; Fleischmann R.; Hall S.; Nicholls D.; Rischmueller M.; Baker M.F.; Bessette L.; Cividino A.A.; Haraoui B.; Niall Jones H.; Keystone E.C.; Khraishi M.; Thorne J.; Birbara C.A.; Baraf H.S.B.; Bathon J.M.; Brodsky A.L.; Cush J.J.; Dikranian A.H.; Diri E.; Dura P.A.; Lohr K.M.; Fleischmann R.M.; Griffin R.M.; Halter D.G.; Hargrove J.K.; Bouda D.W.; Reddy Pasya S.K.; Hill G.L.; Jackson R.E.; Kafka S.P.; Kaine J.L.; Katzenstein P.L.; Kempf K.J.; Kolba K.S.; Kremer J.M.; Longley S.; Mathews S.D.; Milton A.C.; Misischia R.J.; Moorman H.A.; Moreland L.W.; Niemer M.W.; Palmer W.R.; Sayers M.E.; Schuette P.T.; Shamim T.; Shergy W.J.; Sikes D.H.; Silverfield J.C.; Siva C.; Taborn J.D.; Walsh B.T.; Wells A.F.; Wolfe S.M.; Adhikari P.; Amano K.; Bae S.-C.; Chandrashekara S.; Chopra A.K.; PING-NING HSU; Iwahashi M.; Kadel J.K.; Kawabe Y.; Koh E.-M.; Lan J.-L.; Lee S.-K.; Lin H.-Y.; Liou L.-B.; Liu M.-F.; Migita K.; Miyamoto T.; Miyasaka N.; Mori S.; Munakata Y.; Ohta S.; Park W.; Park S.-H.; Rao U.R.; Shim S.C.; Shobha V.; Takasaki Y.; Takeuchi T.; Tanaka Y.; Tohma S.; Tsai W.-C.; Ueki Y.; Veeravalli S.C.M.; Wagh S.; Yamanaka H.; Yoo B.; Batalov A.; Bichoversuska D.; Dvorak Z.; Goranov I.; Hrytsenko H.M.; Kopackova J.; Mosterova Z.; Oparanov B.; Petrov A.; Pokrzywnicka-Gajek I.; Povoroznyuk V.V.; Rosa J.; Ruzga Z.; Settas L.; Stanislavchuk M.A.; Tseluyko V.I.; Vitek P.; de Freitas Zerbini C.A.; Brenol J.C.T.; Cardiel-Rios M.H.; Escalante W.J.O.; Maldonado-Lopez M.C.; Jaller Raad J.J.; Hernandez J.D.M.; Jauregui E.A.; Keiserman M.W.; Melazzi A.C.C.; Pascual-Ramos V.; Pinto L.T.; Radominski S.C.; Ximenes A.C.; de Morales S.V.; the ORAL Scan Investigators |
| 臺大學術典藏 |
2019-02-13T05:12:56Z |
Tofacitinib in patients with moderate-to-severe chronic plaque psoriasis: long-term safety and efficacy in an open-label extension study
|
TSEN-FANG TSAI; TSEN-FANG TSAI |
| 臺大學術典藏 |
2020-10-22T07:27:45Z |
Tofacitinib in patients with moderate-to-severe chronic plaque psoriasis: long-term safety and efficacy in an open-label extension study
|
Gardner A.C.; Valdez H.; Tallman A.; Tan H.; Ports W.C.; Harper M.K.; TSEN-FANG TSAI; Valenzuela F.;Korman N.J.;Bissonnette R.;Bakos N.;Tsen-Fang Tsai;Harper M.K.;Ports W.C.;Tan H.;Tallman A.;Valdez H.;Gardner A.C.; Valenzuela F.; Korman N.J.; Bissonnette R.; Bakos N. |
| 臺大學術典藏 |
2017-10 |
Tofacitinib in psoriatic arthritis
|
TSEN-FANG TSAI; Ting-Shun Wang and Tsen-Fang Tsai |
| 臺大學術典藏 |
2020-10-22T07:27:48Z |
Tofacitinib in psoriatic arthritis
|
TSEN-FANG TSAI; Wang T.-S. |
| 臺大學術典藏 |
2021-02-02T02:47:53Z |
Tofacitinib in the treatment of moderate-to-severe rheumatoid arthritis: a cost-effectiveness analysis compared with adalimumab in Taiwan
|
Chen D.-Y.; PING-NING HSU; Tang C.-H.; Claxton L.; Valluri S.; Gerber R.A. |
| 國立成功大學 |
2023 |
Tofacitinib treatment in anti-glycyl-tRNA synthetase antibody interstitial lung disease – A case report
|
Tseng, C.-W. |
| 臺大學術典藏 |
2018-09-10T15:28:29Z |
Tofacitinib, an oral Janus kinase inhibitor, for the treatment of chronic plaque psoriasis: Results from two randomized, placebo-controlled, phase III trials
|
Papp, K.A.;Menter, M.A.;Abe, M.;Elewski, B.;Feldman, S.R.;Gottlieb, A.B.;Langley, R.;Luger, T.;Thaci, D.;Buonanno, M.;Gupta, P.;Proulx, J.;Lan, S.;Wolk, R.; TSEN-FANG TSAI |
